06 Jun, EOD - Indian

SENSEX 82188.99 (0.92)

Nifty 50 25003.05 (1.02)

Nifty Bank 56578.4 (1.47)

Nifty IT 37294.85 (0.50)

Nifty Midcap 100 59010.3 (1.21)

Nifty Next 50 67992.85 (1.26)

Nifty Pharma 21684.4 (0.19)

Nifty Smallcap 100 18582.45 (0.81)

06 Jun, EOD - Global

NIKKEI 225 37741.61 (0.50)

HANG SENG 23792.55 (-0.48)

S&P 6030.7 (1.18)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoVilin Bio Med Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 78871 | NSE Symbol : VILINBIO | ISIN : INE0L4V01013 | Industry : Pharmaceuticals - Indian - Bulk Drugs |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
10-May-2025 17-May-2025 Accounts To consider and approve the Audited Financial Results for the period ended March 31, 2025 Vilin Bio Med Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025. (As Per NSE Announcement Dated On : 17.05.2025)
23-Jan-2025 23-Jan-2025 Change in Directors Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on January 23, 2025. (As Per NSE Announcement Dated on: 23/01/2025)
04-Jan-2025 10-Jan-2025 Change in Directors To consider Fund Raising and other business matters Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on January 10, 2025. (As Per NSE Announcement Dated on: 10/01/2025) Due to omission on our part, we are here by submitting the outcome of the board meeting for your record (As Per NSE Announcement Dated on: 22.01.2025)
23-Oct-2024 30-Oct-2024 Quarterly Results To consider and approve the financial results for the period ended September 30, 2024 Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on October 30, 2024. (AS Per NSE Announcement Dated on: 30/10/2024)
03-Oct-2024 03-Oct-2024 Change in Directors Vilin Bio Med Limited has informed the Exchange regarding Appointment of Mr. Yadamakanti Madhu Sudhan Reddy as Managing Director of the company w.e.f. October 03, 2024.
16-Aug-2024 22-Aug-2024 AGM To consider matters related to the Annual General Meeting and other business matters Vilin Bio Med Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2024. (As Per NSE Announcement Dated on: 22/08/2024)
20-May-2024 29-May-2024 Quarterly Results To consider and approve the financial results for the period ended March 31, 2024 Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on May 29, 2024. (As Per NSE Announcement Dated on: 29/05/2024)
04-May-2024 04-May-2024 Change in Other Executives The Board of Directors of the Company at their meeting held today has Appointed Mr. ANAND LOHIA (Membership No: A48220) as Company Secretary and Compliance Officer of the Company w.e.f. May 04, 2023, in pursuant to Section 203 of Companies Act, 2013 and under Regulation 6 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
24-Feb-2024 24-Feb-2024 Change in Other Executives Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on February 24, 2024.
01-Feb-2024 08-Feb-2024 Raising funds through Debt Instr. To consider Fund Raising and other business matters Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on February 08, 2024. (As Per NSE Announcement Dated on: 08/02/2024)
30-Oct-2023 10-Nov-2023 Half Yearly Results To consider and approve the financial results for the period ended September 30, 2023 Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on November 10, 2023. (As Per NSE Announcement Dated on: 10/11/2023) Vilin Bio Med Limited has informed the Exchange regarding 'Submission of Revised Outcome of the Board Meeting held on November 10, 2023 as per NSE/CML/2018/02 dated January 16, 2018'. (As Per NSE Announcement Dated on: 14/12/2023)
16-Aug-2023 24-Aug-2023 AGM To consider other business matters related to the 17th Annual General Meeting of the Company VILIN BIO MED LIMITED has informed the Exchange about Board Meeting to be held on 24-Aug-2023 to consider Other business.
02-Aug-2023 02-Aug-2023 Change in Other Executives Vilin Bio Med Limited has informed the Exchange regarding Appointment of Ms ASHDEEP KAUR as Company Secretary & Compliance Officer of the company w.e.f. August 02, 2023. Vilin Bio Med Limited has informed the Exchange regarding Resignation of Mr SAKET KANSAL as Company Secretary & Compliance Officer of the company w.e.f. August 02, 2023.
08-Jul-2023 19-Jul-2023 Accounts To consider and approve the financial results for the period ended March 31, 2023 and other business matters VILIN BIO MED LIMITED has informed the Exchange about Board Meeting to be held on 19-Jul-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Other business. Vilin Bio Med Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. Vilin Bio Med Limited has informed the Exchange regarding Board meeting held on July 19, 2023. (As Per NSE Announcement Dated on 19/07/2023)
1 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +